Specialty Chemicals

Aspen Aerogels

Aspen Aerogels Announces Q3 Earnings and Wins Design Award from Major European Auto OEM

Aspen Aerogels released FY2025 9 Months Earnings on November 6 Pre-Market EST, with actual revenue of USD 229.76 M and EPS of USD -3.861

Aspen Aerogels released FY2025 Q3 earnings on November 6 Pre-Market EST, actual revenue USD 73.02 M (forecast USD 73.42 M), actual EPS USD -0.08 (forecast USD -0.0216)

Aspen Aerogels Reports 38% Revenue Drop in Q3 Misses Estimates

Aspen Aerogels to Release FY2025 Q3 Earnings on November 6, Pre-Market EST; Forecast Revenue USD 73.42 M, EPS USD -0.0216

Five-star Analyst Stine Covers Industrial Stocks and Rates Aspen Aerogels

Aspen Aerogels stock price rises but revenue falls

Barclays Downgrades Aspen Aerogels Rating

Aspen Aerogels released FY2025 Q2 earnings on August 7 Pre-Market (EST), actual revenue USD 78.02 M (forecast USD 72.53 M), actual EPS USD -0.1101 (forecast USD -0.1133)

Aspen Aerogels released FY2025 Semi-Annual Earnings on August 7 Pre-Market EST, with actual revenue of USD 156.75 M and EPS of USD -3.78

Aspen Aerogels reports a net loss of $9.1 million for Q2

Aspen Aerogels to release FY2025 Q2 earnings on August 7 Pre-Market EST, forecast revenue USD 72.53 M, EPS USD -0.1133

Aspen Aerogels to Release Q2 2025 Earnings

Aspen Aerogels Stock Price Down, Revenue Declines in Q4 Earnings

Two Sigma Acquired Shares of Aspen Aerogels

Barclays downgrades Aspen Aerogels stock rating and price target

Aspen Aerogels Executives to Attend B. Riley's Annual Investor Conference

Aspen Aerogels CEO Buys Shares

FactSet Survey Analysts Give Aspen Aerogels Inc an 'Outperform' Rating

Aspen Aerogels released FY2025 Q1 earnings on May 8 Pre-Market EST, actual revenue USD 78.72 M (forecast USD 82.75 M), actual EPS USD -3.6708 (forecast USD -0.0706)

A SPAC III Acquisition

PicoCELA

Davis Commodities

Society Pass

ECD Automotive Design

Gauzy

Bristol-Myers Squibb Company

A SPAC III ACQUISITION CORP. COM NPV CL A (SUBS/RTS)02/01/2026

Paranovus ENT Tech

Cue BioPharma

Shin-Etsu Chemical Co., Ltd.

Givaudan

Symrise

Newmarket

Balchem

Sensient Tech

Flotek Industries

Solesence

Northern Tech

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap